Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D014013 |
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt |
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Rotenone results in increased expression of BECN1 protein] | decreases reaction|increases expression | 18032788
|
D014013 |
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt |
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Thenoyltrifluoroacetone results in increased expression of BECN1 protein] | decreases reaction|increases expression | 18032788
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of BECN1 mRNA | affects expression | 21346803
|
C025946 |
3-methyladenine |
3-methyladenine inhibits the reaction [BECN1 protein results in decreased susceptibility to Staurosporine] | decreases reaction|decreases response to substance | 16497721
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of BECN1 mRNA | increases expression | 18648102
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of BECN1 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of BECN1 protein | increases expression | 16882451
|
C006632 |
arsenic trioxide |
Cycloheximide inhibits the reaction [arsenic trioxide results in increased expression of BECN1 protein] | decreases reaction|increases expression | 16882451
|
D002330 |
Carmustine |
Carmustine results in decreased expression of BECN1 mRNA | decreases expression | 15980968
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [arsenic trioxide results in increased expression of BECN1 protein] | decreases reaction|increases expression | 16882451
|
D003520 |
Cyclophosphamide |
BECN1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
C014347 |
decitabine |
decitabine inhibits the reaction [sodium arsenite results in increased expression of BECN1 protein] | decreases reaction|increases expression | 19577553
|
D004317 |
Doxorubicin |
BECN1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D004317 |
Doxorubicin |
BECN1 protein affects the susceptibility to Doxorubicin | affects response to substance | 16718815
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of BECN1 mRNA | increases expression | 19001878
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of BECN1 protein | increases expression | 19001878
|
D004317 |
Doxorubicin |
PARP1 protein promotes the reaction [Doxorubicin results in increased expression of BECN1 mRNA] | increases expression|increases reaction | 19001878
|
D004317 |
Doxorubicin |
PARP1 protein promotes the reaction [Doxorubicin results in increased expression of BECN1 protein] | increases expression|increases reaction | 19001878
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BECN1 mRNA | affects cotreatment|increases expression | 17942748
|
D005472 |
Fluorouracil |
BECN1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased expression of BECN1 protein | increases expression | 19451193
|
D007657 |
Ketone Bodies |
Ketone Bodies results in decreased expression of BECN1 mRNA | decreases expression | 16807920
|
D017239 |
Paclitaxel |
BECN1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D012402 |
Rotenone |
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Rotenone results in increased expression of BECN1 protein] | decreases reaction|increases expression | 18032788
|
D012402 |
Rotenone |
BECN1 protein affects the susceptibility to Rotenone | affects response to substance | 18032788
|
D012402 |
Rotenone |
Rotenone results in increased expression of BECN1 protein | increases expression | 18032788
|
D012402 |
Rotenone |
SOD2 protein inhibits the reaction [Rotenone results in increased expression of BECN1 protein] | decreases reaction|increases expression | 18032788
|
C017947 |
sodium arsenite |
decitabine inhibits the reaction [sodium arsenite results in increased expression of BECN1 protein] | decreases reaction|increases expression | 19577553
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of BECN1 protein | increases expression | 19577553 17683884
|
C017947 |
sodium arsenite |
U 0126 inhibits the reaction [sodium arsenite results in increased expression of BECN1 protein] | decreases reaction|increases expression | 19577553
|
D019311 |
Staurosporine |
3-methyladenine inhibits the reaction [BECN1 protein results in decreased susceptibility to Staurosporine] | decreases reaction|decreases response to substance | 16497721
|
D019311 |
Staurosporine |
BECN1 protein results in decreased susceptibility to Staurosporine | decreases response to substance | 16497721
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BECN1 mRNA | affects cotreatment|increases expression | 17942748
|
D013804 |
Thenoyltrifluoroacetone |
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Thenoyltrifluoroacetone results in increased expression of BECN1 protein] | decreases reaction|increases expression | 18032788
|
D013804 |
Thenoyltrifluoroacetone |
BECN1 protein affects the susceptibility to Thenoyltrifluoroacetone | affects response to substance | 18032788
|
D013804 |
Thenoyltrifluoroacetone |
SOD2 protein inhibits the reaction [Thenoyltrifluoroacetone results in increased expression of BECN1 protein] | decreases reaction|increases expression | 18032788
|
D013804 |
Thenoyltrifluoroacetone |
Thenoyltrifluoroacetone results in increased expression of BECN1 protein | increases expression | 18032788
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [sodium arsenite results in increased expression of BECN1 protein] | decreases reaction|increases expression | 19577553
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.72 | 14514962 15322242 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.43 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.81 | 17505938 |
MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
5.34 | 17694057 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
9.92 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
9.92 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
9.92 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
9.92 | 17638652 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.68 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.25 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.57 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.77 | 16712894 17306315 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.42 | 21441931 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.29 | 17963324 16511603 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.29 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
9.74 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
9.74 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.58 | 15885639 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.89 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
8.56 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.56 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.66 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.68 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.57 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.44 | 15867366 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
8.74 | 16187019 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
8.74 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.91 | 12006526 11325840 15093573 18323546 15136595 18234424 16978400 17388661 17020986 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.91 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.91 | 16096432 19526202 18695136 17369602 15939500 18234424 18628466 16595493 16264153 15136595 16115903 17983394 17426702 15634643 15993339 16935488 15692762 16322301 16826403 15668708 15567936 11325840 18382427 15994142 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.91 | 19217205 15136595 16110121 18608205 18357371 16595493 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
2.91 | 18323546 15136595 11325840 16244791 16115903 16273361 18234424 18223236 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.91 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.20 | 11589617 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
11.92 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
11.92 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.84 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.84 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
16.58 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
16.58 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
16.58 | 15073043 16217749 11135700 14691202 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
16.58 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
16.58 | 18059187 16234567 17876044 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
16.58 | 17971768 17045692 17088986 16799960 18930000 16332177 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
16.58 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
16.58 | 15276417 16507464 17306315 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.76 | 16152834 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.75 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
14.89 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
14.89 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
14.89 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
14.89 | 18695887 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.00 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
10.52 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
10.52 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
10.52 | 18986760 17066447 16280240 16757204 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
10.52 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.30 | 18670907 16120746 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.44 | 17007740 16731534 17924179 17519947 15811867 17308081 16952015 15476868 16278810 17131338 16242529 17329180 17974986 16364871 17928571 16612575 15792986 17351982 16455267 16109756 18627295 15505089 16651473 16269455 17382496 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.90 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
3.42 | 16936243 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
10.68 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
10.68 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
10.68 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
7.54 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.54 | 17110522 15861022 17333356 16105132 17681005 16919318 11677210 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.05 | 15340226 8697196 15668235 12621046 16354765 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
3.79 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.79 | 15001691 17016597 16510598 17169374 17725105 18772588 17172411 17018589 17287894 16340194 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
6.35 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
6.35 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
6.35 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
6.35 | 17094418 17695437 15289873 16282729 18288408 18383874 16331619 16524972 17401013 18802399 15148649 18509181 17016601 16303861 17255274 17454858 17594712 16391804 14970324 18448328 18949393 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
6.35 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.95 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.06 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.43 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.43 | 15322242 10048152 20055451 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.89 | 18551238 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.86 | 18372110 16651033 16989017 16614059 15276878 10498854 11948286 17010015 16413132 12913760 12388444 18093676 17979934 15643279 18295254 18710439 18483878 18433785 10700343 12161096 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.66 | 16733453 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.97 | 15213294 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.68 | 2524372 11906362 12868966 8970840 8156756 11298694 14531868 18759878 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.37 | 2952479 3621924 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
3.96 | 15331540 10990075 11751995 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.18 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.64 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
8.66 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
8.66 | 18692083 7440962 11289319 9328219 8291058 1440618 6679447 16192314 18648102 18289764 6482804 9653073 9022650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
8.66 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.66 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.79 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.79 | 11462148 |
MESH:D004487 |
Edema |
|
Staurosporine |
6.83 | 8273558 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.83 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.77 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.06 | 12538720 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.99 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.37 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.91 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.03 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.09 | 11006010 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.16 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
10.16 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
10.16 | 16785472 15173087 16481741 16337965 17638652 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
10.16 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.91 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
7.34 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
7.34 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.33 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.89 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.46 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.82 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.13 | 16904648 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.55 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
7.30 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.30 | 17150277 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.82 | 16145905 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.38 | 11389073 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.91 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.47 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.90 | 11014644 16376943 15172196 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
12.51 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
12.51 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
12.51 | 15102660 18337622 15162350 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.26 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.39 | 12587719 16495754 16144979 18006777 18674790 16879835 17888722 17875725 16244371 16244372 16707910 14766674 16330681 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.26 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.78 | 15692506 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.16 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.21 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.40 | 14986274 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.39 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.76 | 15340226 16120746 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
11.72 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
11.72 | 15147373 17606976 18501091 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
11.72 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.92 | 16959395 16354765 18606429 8697196 15340226 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.81 | 15034207 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.86 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.68 | 16945680 16569931 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.20 | 16076520 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.34 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
15.37 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
15.37 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
15.37 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
15.37 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.79 | 12878042 12200463 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.89 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.03 | 15699352 15369732 16775033 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.03 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
9.72 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
9.72 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
11.82 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.82 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
11.82 | 16985049 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
10.23 | 15070760 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
10.23 | 10602166 |
MESH:D007938 |
Leukemia |
|
decitabine |
10.23 | 19235587 18980019 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.03 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.44 | 17008537 17658394 17296974 17802794 18587576 18172266 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.67 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
11.31 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
11.31 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
8.29 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
8.29 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
9.18 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
9.18 | 17236224 19117987 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.91 | 19850784 20471514 16467208 17050201 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
3.91 | 18704418 17679729 19387464 18460780 18206229 19010910 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.33 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.13 | 19225113 12679006 15748426 17649720 16331271 19075265 15336539 15213294 15622746 11161223 16330433 17869043 16966277 16891316 17712046 19035177 12018890 17107899 17217047 19642359 9834237 11468182 16112521 12712474 16823087 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.22 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.83 | 11830472 10052129 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.70 | 17353645 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.11 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.39 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.39 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
13.72 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
13.72 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
13.72 | 17045692 15113037 18383874 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
13.72 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.72 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
17.78 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
17.78 | 6587162 3712494 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
17.78 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
17.78 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
17.78 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.25 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.08 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
6.42 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
6.42 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
6.42 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.42 | 16712894 17306315 19931552 17077188 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.42 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.66 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
12.14 | 12854902 |
MESH:D008223 |
Lymphoma |
|
decitabine |
12.14 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
12.14 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.47 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
14.05 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
14.05 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
14.05 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.44 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
2.95 | 15458769 |
MESH:D008545 |
Melanoma |
|
Carmustine |
9.58 | 12393984 |
MESH:D008545 |
Melanoma |
|
decitabine |
9.58 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
9.58 | 16827129 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
9.58 | 12025231 16342250 12040289 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
9.58 | 19082730 16487513 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.67 | 16388313 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.01 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.38 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.53 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.66 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
11.67 | 15949261 19549372 14977855 19417148 11468182 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
11.67 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
11.67 | 14749477 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.54 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.25 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.25 | 19010910 19157545 18608210 16882708 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.90 | 19429709 15857846 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.91 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.73 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.83 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
9.31 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
9.31 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
9.31 | 15867366 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
11.41 | 18854779 |
MESH:D009369 |
Neoplasms |
|
decitabine |
11.41 | 19116145 17925555 19470736 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
11.41 | 18600527 16928823 18239605 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
11.41 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.54 | 20056578 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.64 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.89 | 15640375 16889571 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.78 | 17356569 18619942 15790535 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.09 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
11.64 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
11.64 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.64 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
6.99 | 8761367 15176712 16115947 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
6.99 | 15555623 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.76 | 8761367 12837982 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.35 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.20 | 8291058 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.49 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.49 | 4026338 6482804 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.58 | 16517039 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.89 | 3988306 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.85 | 15867366 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.01 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
14.57 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
14.57 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
14.57 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
14.57 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
14.57 | 16211241 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.52 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
12.01 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
12.01 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
12.01 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
12.01 | 19003803 16929163 16500647 15113037 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.56 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
8.88 | 7296757 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
8.88 | 12065085 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.04 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
2.93 | 15451049 16412576 19114014 18619942 11535288 19232380 11445065 18191903 16140633 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.96 | 18197244 15795934 15574749 15927086 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.12 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.34 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.03 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.03 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.43 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.73 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.06 | 11896295 11399792 11118676 11222880 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.60 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
1.89 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
1.89 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.89 | 15897917 16868541 18437689 15749863 16888761 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
1.89 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
1.89 | 16356831 17172428 17136230 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.89 | 16039940 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.18 | 15861022 16919318 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.23 | 16636934 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.90 | 18722050 15538739 16160472 18286688 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.09 | 17922066 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.28 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.28 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.87 | 18313854 16767912 15625365 15675481 17710206 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
9.85 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
9.85 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.66 | 17846226 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.70 | 16636934 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.45 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
13.10 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
13.10 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.10 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.10 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.44 | 16767912 17203757 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.81 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.38 | 16517039 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.69 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
4.67 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
4.67 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
4.67 | 18567086 16424979 19015929 16951190 18396642 19084572 17522103 17498489 15786421 17172411 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
4.67 | 18506536 18396642 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.93 | 12837982 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.68 | 16930453 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.50 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.04 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.77 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
16.30 | 3712494 1399818 6582329 7505956 6587162 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
16.30 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
16.30 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
16.30 | 17909728 16010429 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.87 | 16280240 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.83 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
23.38 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
23.38 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
23.38 | 11780464 12845720 12973940 20435036 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
23.38 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
23.38 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
23.38 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
23.38 | 17306315 16452187 16712894 11723127 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.19 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
9.10 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.10 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.17 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.78 | 17785578 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.29 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.47 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.42 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.09 | 17334414 17678736 16364871 17638931 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.12 | 15886252 |